TLR4 and inflammatory bowel disease: LPS activates the host Toll-like receptor 4 (TLR4) to induce the production of pro-inflammatory cytokines and apoptosis of intestinal epithelial cells in IBD, which contribute to cytokine-mediated mucosal tissue damage, leading to a breakdown in the mucosal barrier [44].